US Patent 11384155 Antigen binding molecules specific for an anti-CD19 scFv
All edits
Edits on 11 Apr, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113841550
Date of Patent
July 12, 2022
0Patent Application Number
168146610
Date Filed
March 10, 2020
0Patent Citations
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113841550
Date of Patent
July 12, 2022
0Patent Application Number
168146610
Date Filed
March 10, 2020
0Patent Citations
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Edits on 23 Sep, 2022
Golden AI
Infobox
Edits on 13 Jul, 2022
Golden AI
Edits made to:
Infobox (+27 properties)
Article (+190 characters)
US Patent 11384155 Antigen binding molecules specific for an anti-CD19 scFv
Article
Isolated antigen binding molecules that specifically bind to an anti-CD19 scFv comprising SEQ ID NO: 1 are provided. The antigen binding molecules can be used in the methods provided herein.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11384155
Date of patent
July 12, 2022
Patent application number
16814661
Date Filed
March 10, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11384155 Antigen binding molecules specific for an anti-CD19 scFv
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
